Main content

    Liver Transplant/Hepatology/Hepatitis/Liver Failure Clinical Trials

    Liver Disease Management & Transplant Program

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov

    Acute Liver Failure including Acute Liver Injury  |  Drug and CAM Induced Liver Injury  |  Hepatitis C  |  Hepatoma  |  Thrombocytopenia

    Acute Liver Failure including Acute Liver Injury

    Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
    Principal Investigator:
    Timothy Davern, MD

    Contact:
    Katherine Fajardo
    415-600-1518
    Email FajardK@cpmcri.org    		 A Multi-Center Trial to Study Acute Liver Failure in Adults (ALFSG)Hospitalized patients who have acute liver failure or acute liver injury. Subjects must be a hospitalized patient. Active/Enrolling

    Back to top

    Drug and CAM Induced Liver Injury

    Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
    Principal Investigator:
    Timothy Davern, MD

    Contact:
    Katherine Fajardo
    415-600-1518
    Email FajardK@cpmcri.org    		 DILIN's Prospective Study.
    A Multicenter, Longitudinal Study of Drug-and CAM-Induced Liver Injury-Drug-Induced Liver Injury Network (DILIN)    		Subjects 2 years who have taken a drug complementary alternative medicine product and developed a liver reaction within the past 6 months. Active/Enrolling

    Back to top

    Hepatitis C

    Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
    Principal Investigator:
    Natalie Bzowej, MD

    Contact:
    Anna von Bakonyi
    415-600-1107
    Email vonbaka@sutterhealth.org    		 Virology Follow up Study in Subjects Previously Treated With TelaprevirPatients previously treated with teleprevir in select clinical trials Active/Enrolling


    Back to top

    Hepatoma

    Please click here to see our Hepatoma clinical trials.


    Back to top

    Thrombocytopenia

    Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
    Principal Investigator:
    Maurizio Bonacini, MD

    Contact:
    Juliana Ma
    415-600-1368
    Email MaJX@cpmcri.org    		 Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic ProceduresSubjects 18 years or greater who have thrombocytopenia related to chronic liver disease and are scheduled to undergo an elective surgical or diagnostic procedure. Active/Enrolling



    • updated December 2011

    Back to top